A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

NCT00888238 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC